Dacogen™ (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting

Dacogen™ (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting

Studies of Nipent® in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented at American Society of Hematology Annual Meeting

Studies of Nipent® in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented at American Society of Hematology Annual Meeting

Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs

Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs

MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen™ (decitabine) Injection for MDS

MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen™ (decitabine) Injection for MDS

Approvable Letter Received from the FDA for Dacogen™ (Decitabine) Injection for the Treatment of MDS

Approvable Letter Received from the FDA for Dacogen™ (Decitabine) Injection for the Treatment of MDS